|
|
Application effect of progesterone sustained-released vaginal gel for luteal phase support in vitro fertilization and embryo transfer |
WANG Mei-xian ZHANG Yang SHAO Xiao-guang |
Reproductive and Genetic Medicine Center of Dalian Women and Children Medical Center,Liaoning Province,Dalian 116000,China |
|
|
Abstract Objective To analyze the efficacy and safety of progesterone sustained-released vaginal gel for luteal phase support in vitro fertilization-embryo transfer(IVF-ET).Methods From January to December 2015,992 patients who were agreed on long-term regimen of IVF-ET were selected.According to different progesterone-support regimens,they were divided into group A(muscular injection progesterone 60 mg,n=56),group B(muscular injection progesterone 40 mg,n=740), and group C(external application of progesterone sustained-released vaginal gel,n=196).The pregnancy rate,implantation rate,multiple-gestation pregnancy rate,miscarriage rate,ectopic pregnancy rate and incidence of adverse drug reactions were compared among the three groups.Results There was no significant difference in pregnancy rate,implantation rate, multiple gestation pregnancy rate,miscarriage rate,orectopic pregnancy rate among the three groups(P>0.05).However,the pregnancy rate,multiple gestation pregnancy rate and implantation rate had increasing tendency,and miscarriage rate was in a decrease tendency in group C.The total incidence of adverse drug reactions was significantly lower than that in the group A and B,the difference was statistically significant(P<0.01).Conclusion Progesterone sustained-released vaginal gel is one of the effective and safe methods for luteal phase support in IVF-ET.
|
|
|
|
|
[1] |
Fatemi HM,Popovic-Todorovic B,Papanikolau E,et al.An update of luteal phase support in stimulated IVF cycles[J]. Hum Reprod Update,2007,13(6):581-590.
|
[2] |
Polyzos NP,Messini CI,Papanikolaou EG,et al.Vaginal pro gesterone gel for luteal phase support in IVF/ICSI cycles:a meta-analysis[J].Fertil Steril,2010,94(6):∶2083-2087.
|
[3] |
孙赟,刘平,叶虹,等.黄体支持与孕激素补充共识[J].生殖与避孕,2015,35(1):1-8.
|
[4] |
Vaisbuch E,de Ziegler D,Leong M,et al.Luteal-phase support in assisted reproduction treatment:real-life practices reported world wide by an updated website-based survey[J]. Reprod Biomed Online,2013,28(3):330-335.
|
[5] |
王春艳,吕丽萍,王崇兰.比较黄体酮阴道缓释凝胶与黄体酮联合地屈孕酮对体外受精的黄体支持[J].中国优生与遗传杂志,2013,21(9):106-107.
|
[6] |
龚斐,蔡素芬,卢光琇.两种阴道给药黄体支持药物在IVF-ET/ICSI后用药的比较研究[J].实用妇产科杂志,2012,28(3):199-201.
|
[7] |
邹红艳,李维麟,王细林,等.黄体酮阴道缓释凝胶在多周期IVF/ICSI-ET黄体支持中的应用价值[J].实用妇产科杂志,2013,29(4):312-315.
|
[8] |
付磊,沙伟,禇大鹏,等.不同促排卵方案在体外受精-胚胎移植中应用的比较[J].武汉大学学报(医学版),2016,37(2):254-257.
|
[9] |
巨瑛,吴静,黄剑磊,等.黄体酮阴道缓释凝胶配伍减量肌内注射黄体酮在体外受精-胚胎移植技术中的应用研究[J].陕西医学杂志,2016,45(5):519-521.
|
[10] |
迟洪滨,周灿权,王树玉,等.黄体酮阴道缓释凝胶在IVF/ICSI周期中作为黄体支持的初步应用[J].实用妇产科杂志,2012,28(11):973-976.
|
[11] |
冷义福,孙绪磊,牟琳琳,等.不同黄体支持方案在新鲜周期和冻融胚胎移植周期中的临床比较[J].中华临床医师杂志(电子版),2015,9(12):2436-2438.
|
[12] |
耿嘉瑄,张翠莲,张少娣.两种黄体酮阴道制剂在IVF/ ICSI-ET黄体支持中的用药比较[J].中国妇幼保健,2014,29(35):5861-5863.
|
[13] |
Silverberg KM,Vaughn TC,Hansard L,et al.Vaginal(Crinone 8%)vs.intramuscular progesterone in oil for luteal phase support in invitro fertilization:a large prospective trial[J].Fertil Steril,2012,97(2):344-348.
|
[14] |
Raghupathy R,Al-Mutawa E,Al-Azemi M,et al.Progesterone-induced blocking factor(PIBF)modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery[J].J Reprod Immunol,2009,80(1-2):91-99.
|
[15] |
Nardo LG.Progesterone supplementation to prevent recurrent miscarriage and to reduce implantation failure in assisted reproductive cycles[J].Reprod Biomed Online,2006,13(1):47-57.
|
|
|
|